| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.99B | +24.7% |
| Cost of Revenue | $641.7M | +43.1% |
| Gross Profit | $1.35B | +17.5% |
| R&D Expense | $362.3M | +17.0% |
| SG&A Expense | $292.9M | +3.0% |
| Operating Income | -$649.5M | -115.2% |
| Interest Expense | $4.8M | -92.5% |
| Pre-tax Income | -$874.1M | -133.9% |
| Income Tax | $5.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $270.0M | +1.1% |
| Accounts Receivable | $311.3M | +33.7% |
| Inventory | $1.2M | -78.6% |
| Current Assets | $796.0M | +22.3% |
| Total Assets | $2.07B | -19.6% |
| Current Liabilities | $652.6M | +24.0% |
| Total Liabilities | $2.36B | +15.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $191.3M | +25.7% |
| Capital Expenditures | $32.7M | +13.0% |
| Investing Cash Flow | -$87.2M | +78.0% |
| Financing Cash Flow | -$98.2M | +22.7% |
| Free Cash Flow | $158.6M | +28.7% |
| +102.3% |
| Net Income | -$879.2M | -133.7% |
| EPS (Basic) | -$9.23 | -125.1% |
| EPS (Diluted) | -$9.23 | -125.1% |
| Stockholders' Equity |
| -$482.8M |
| -242.4% |